| Apr 8 2024 |
Closing the Loopholes: The Biden-Harris Administration’s Action Against “Junk Insurance” |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 5 2024 |
McDermottPlus Check-Up: April 5, 2024 |
McDermott Will & Emery |
| Apr 5 2024 |
Pharmaceutical Companies May Be the First Targets of the Washington State My Health My Data Act |
Greenberg Traurig, LLP |
| Apr 5 2024 |
CMS ISSUES ITS 2025 FINAL RULE: Aligning with the FCC, CMS Requires TPMOs to Obtain Beneficiary’s Prior Express Written Consent Prior to Sharing Personal Data with Other TPMOs – Even if “Manually” Dialing! |
Troutman Amin, LLP |
| Apr 5 2024 |
As Temperatures Start to Rise, OSHA Takes Steps to Implement Rules Concerning Heat Illness Prevention |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 5 2024 |
Anti-Kickbacks, Pro Patients: Whistleblower Exposes Oncology Practice’s Kickback Scheme |
Tycko & Zavareei LLP |
| Apr 4 2024 |
Washington State and Seattle Paid Sick and Safe Leave Updates |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 4 2024 |
Pack Rat Shareholders: Dealing with Hoarding in Cooperatives |
Norris McLaughlin P.A. |
| Apr 4 2024 |
HHS Health Care Cybersecurity Performance Goals: Proposed Incentives, Penalties and Compliance Standards Review |
Mintz |
| Apr 4 2024 |
Cancer Drugs (Antibody Drug Conjugates): An FDA Perspective |
Foley & Lardner LLP |
| Apr 4 2024 |
FDA Reminds Stakeholders of Animal Drug ‘Approved by FDA’ Labeling Requirements |
Greenberg Traurig, LLP |
| Apr 3 2024 |
Time to Pay Up: Doctors and Marketers Pay $1.5 Million Settlement for Medicare Referral Kickback Scheme |
Tycko & Zavareei LLP |
| Apr 3 2024 |
FTC’s Campaign Against Improper Orange Book Listings Continues with Amicus Brief in Teva’s Challenge of Amneal Asthma Inhaler ANDA |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 3 2024 |
FDA Warning Letter Is a Stark Reminder that if You Claim Your Product Is RUO, it Has to Be RUO |
Mintz |
| Apr 3 2024 |
Two New Proposed Rules for Medicare Advantage Plans Expands Beneficiary Rights |
Norris McLaughlin P.A. |
| Apr 3 2024 |
US FDA to Develop Regulatory Scheme for AI in Medical Products, Foster International Cooperation |
Greenberg Traurig, LLP |
| Apr 3 2024 |
Continuity in Coverage: CMS Extends the Unwinding SEP & Issues Final Rule for Medicaid and CHIP Enrollment |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 3 2024 |
The “Fix” Is In: Alabama Legislature to Consider Controversial Proposal to Revamp Stalled Medical Cannabis Program |
Bradley Arant Boult Cummings LLP |
| Apr 3 2024 |
Importance of Negotiating Assignment and Subletting Provisions in Health Care Leases |
Epstein Becker & Green, P.C. |
| Apr 3 2024 |
This Week in 340B: March 19 – 25, 2024 |
McDermott Will & Emery |
| Apr 3 2024 |
This Week in 340B: March 13 – 18, 2024 |
McDermott Will & Emery |
| Apr 3 2024 |
This Week in 340B: March 26 – April 1, 2024 |
McDermott Will & Emery |
| Apr 3 2024 |
OSH Law Primer, Part IV: The General Duty Clause |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 2 2024 |
Examining Community Benefit: The IRS' Shifting Standards for Tax-Exempt Hospitals |
Polsinelli PC |
| Apr 2 2024 |
Happy National Employee Benefits Day 2024! |
Jackson Lewis P.C. |
| Apr 2 2024 |
Unpacking Averages: Adverse Events for Device-Lead Combination Products |
Epstein Becker & Green, P.C. |
| Apr 2 2024 |
OSHA Issues Final Rule Allowing Employee Third-Party Representatives to Enter Workplace – Including Labor Unions |
Proskauer Rose LLP |
| Apr 2 2024 |
Advancing Interoperability and Improving Prior Authorization: No One Said It Would Be Easy! |
Epstein Becker & Green, P.C. |
| Apr 2 2024 |
California Considers New Restrictions as Health Care Notice Requirements Go Live for Transactions Closing on or After April 1 |
Proskauer Rose LLP |
| Apr 1 2024 |
OSHA Final Rule Clarifies Employees’ Walkaround Representative; Opens Non-Union Workplaces to Union Representatives (US) |
Squire Patton Boggs (US) LLP |
| Apr 1 2024 |
OIG Sparks Public Excitement about Managed Care and Alludes to Incoming Enforcement Guidance |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 1 2024 |
ONC’s “Information Blocking Enhancements” Under the HTI-1 Rule Are in Effect |
Epstein Becker & Green, P.C. |
| Apr 1 2024 |
FDA: New Guidance for Non-interventional Studies of Drug Safety and Effectiveness |
Foley & Lardner LLP |
| Apr 1 2024 |
OSHA’s New Walkaround Rule Raises Unionization, Constitutional Concerns for Employers |
Jackson Lewis P.C. |
| Apr 1 2024 |
Considerations When Employing Workers in a Country Where the Company Currently Has No Employees |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
